Jeffrey M. Fryer
Net worth: 1 M $ as of 2024-03-30
Profile
Jeffrey M.
Fryer is the founder of Rallybio LLC and Rallybio Corp.
(founded in 2018).
At Rallybio Corp., he held the title of Chief Financial Officer & Treasurer until 2023.
He previously worked at Alexion Pharmaceuticals, Inc. as Chief Tax Officer & Vice President from 2008 to 2017.
Mr. Fryer has a graduate degree from the University of Hartford and an undergraduate degree from Bryant University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RALLYBIO CORPORATION
1.67% | 2023-03-30 | 632,370 ( 1.67% ) | 1 M $ | 2024-03-30 |
Former positions of Jeffrey M. Fryer
| Companies | Position | End |
|---|---|---|
| RALLYBIO CORPORATION | Founder | 2023-01-31 |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2017-03-31 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | - |
Training of Jeffrey M. Fryer
| University of Hartford | Graduate Degree |
| Bryant University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
- Stock Market
- Insiders
- Jeffrey M. Fryer
